NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-268-2010-0-PCT-02 Treatment of Inflammatory Diseases by Targeting the Adaptor Protein CIKS PCT PCT PCT/US2011/062945 Expired
NCI E-058-2015-0-US-01 THE MECHANISM OF NSAID CHEMOPREVENTION IN COLORECTAL CANCER US 61/565,540 Abandoned
NCI E-039-2011-0-CA-04 Chimeric Rabbit/Human ROR1 Antibodies CA National Stage 2818992 Issued
NCI E-039-2011-0-EP-05 Chimeric Rabbit/Human ROR1 Antibodies EP National Stage 11791733.6 Issued
NCI E-039-2011-0-AU-03 Chimeric Rabbit/Human ROR1 Antibodies AU National Stage 2011336650 Issued
NCI E-039-2011-0-PCT-02 Chimeric Rabbit/Human ROR1 Antibodies PCT PCT PCT/US2011/062670 Expired
NIAAA E-061-2010-0-CN-07 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE CN National Stage 200980159591.4 Pending
NCI E-018-1999-1-US-03 Molecular Motor US DIV 13/306,774 8798980 Abandoned PDF
NCI E-178-2009-0-US-03 Anti-Tnf Induced Apoptosis (ATIA) Diagnostic Markers And Therapies US National Stage 13/322,863 9989533 Abandoned PDF
NIAID E-089-2002-1-US-45 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US DIV 13/305,639 9783787 Expired PDF
NCI E-304-2006-0-US-04 Modified T Cell Receptors and Related Materials and Methods US DIV 13/304,841 9128080 Issued PDF
NHLBI E-082-2001-0-US-04 Real-Time, Interactive Volumetric Magnetic Resonance Imaging US CON 13/305,496 9008751 Expired PDF
NCI E-195-2001-0-JP-18 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury JP DIV 2011-256095 Expired
NIAID E-078-2009-0-US-04 Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses US National Stage 13/322,317 8568739 Abandoned PDF
NCI E-173-2012-1-US-01 Programmed Death Ligand-1 (PDL1)-transduced K562 Cells Convert Human Th1 Cells Into Regulatory T Cells US 61/564,174 Abandoned
NCI E-173-2012-0-US-01 USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS US 61/563,273 Abandoned
NCI E-196-2000-0-US-06 Defensin-Antigen Fusion Proteins US DIV 13/303,081 8551936 Abandoned PDF
NCI E-119-2011-0-PCT-01 Gene Expression Signature For The Prognosis of Epithelial Cancer PCT PCT PCT/US2011/061871 Expired
NIA E-019-2011-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA PCT PCT PCT/US2011/061872 Abandoned
NCATS E-277-2011-0-US-01 Modulators Of Lipid Storage US 61/562,894 Abandoned
NCI E-255-2011-0-US-01 A Method for Positively or Negatively Regulating the Assembly of Newly Synthesized CENP-A to Exogenous Alphoid DNA Containing CENP-B Boxes in Mammalian Cell Lines US 61/562,825 Abandoned
NCI E-188-1996-0-JP-08 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME JP DIV 2007-284431 Abandoned
NINDS E-206-2011-2-US-01 USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TRZAT GAUCHER'S DISEASE US 61/561,747 Abandoned
NCI E-254-2005-2-NZ-14 Codon Optimized IL-15 and IL-15R-Alpha Genes for Expression in Mammalian Cells NZ DIV 596494 Issued
NCI E-039-2012-0-US-01 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP): A Novel Concept For HIV Treatment US 61/561,257 Abandoned
NCI E-038-2012-0-US-01 Development Of Therapeutic RNA Switches To Eradicate Viral Reservoirs In HIV-Infected Patients US 61/561,247 Abandoned
NCI E-076-2013-0-US-02 Bispecific EGFRvIII Antibody Engaging Molecules US ORD 13/296,809 9249217 Issued PDF
NCI E-181-2009-2-US-02 Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain and Methods of Use US National Stage 13/320,726 9175038 Abandoned PDF
NCI E-290-2006-2-US-13 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-10a US DIV 13/296,500 8343725 Abandoned PDF
NCI E-290-2006-2-US-10 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-29a US DIV 13/296,448 8338106 Abandoned PDF
NCI E-290-2006-2-US-09 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-203 US DIV 13/296,371 8338105 Abandoned PDF
NCI E-290-2006-2-US-12 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-103-2 US DIV 13/296,291 8338104 Abandoned PDF
NCI E-125-2011-2-PCT-01 ANTIBODIES FOR TUMOR GANGLIOSIDES PCT PCT COMB PCT/US2011/060759 Expired
NCI E-290-2006-2-US-14 METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21 US DIV 13/296,545 Abandoned
NIDCR E-032-2013-0-US-01 METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS US 61/629,298 Abandoned
NCI E-097-2009-0-US-04 ANTI-HUMAN ROR1 ANTIBODIES US National Stage 13/265,582 9316646 Issued PDF
NCI E-290-2006-2-US-08 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-16b US DIV 13/295,440 8518647 Abandoned PDF
NCI E-290-2006-2-US-11 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING let-7g US DIV 13/295,280 8349568 Abandoned PDF
NCI E-290-2006-2-US-15 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-106a US DIV 13/295,692 8338103 Abandoned PDF
NCI E-290-2006-2-US-07 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES US DIV 13/295,209 8338102 Abandoned PDF
NCI E-025-2011-2-PCT-01 Antibodies To Tumor Endothelial Marker 8 PCT PCT COMB PCT/US2011/060583 Expired
NCI E-025-2011-2-EP-02 Antibodies To Tumor Endothelial Marker 8 EP National Stage 11840238.7 Abandoned
NIAID E-241-2011-0-US-01 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES US 61/559,359 Abandoned
NIAID E-357-2001-1-AU-12 Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virusf AU DIV 2011250694 Expired
NIAID E-281-2011-0-US-01 Synthetic Catalase/Superoxide Dismutase Mimetics and Methods For Treating Viral Infections US 61/558,137 Abandoned
NCI E-013-2012-0-US-01 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY US 61/558,402 Abandoned
NHLBI E-248-2011-0-US-01 METHODS FOR DETECTING INFECTIOUS AGENTS AND A NOVEL PARVOVIRUS DETECTED THEREBY US 61/558,363 Abandoned
NIAID E-061-2012-0-US-01 ASSAY FOR DIABETES-ASSOCIATED AUTOANTIBODIES US 61/558,193 Abandoned
CC E-173-2011-0-CN-05 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING CN National Stage 201180054995.4 Issued
CC E-173-2011-0-EP-03 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING EP National Stage 11787946.0 Issued